Exact Mass: 430.01173100000005
Exact Mass Matches: 430.01173100000005
Found 95 metabolites which its exact mass value is equals to given mass value 430.01173100000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Bicalutamide
C18H14F4N2O4S (430.06103720000004)
Bicalutamide is only found in individuals that have used or taken this drug. It is an oral non-steroidal anti-androgen for prostate cancer. It binds to the androgen receptor.Bicalutamide competes with androgen for the binding of androgen receptors, consequently blocking the action of androgens of adrenal and testicular origin which stimulate the growth of normal and malignant prostatic tissue. L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BB - Anti-androgens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Isocespitol
2-((2-(4-Bromophenyl)-2-oxoethyl)sulfanyl)-3-isobutyl-4(3H)-quinazolinone
C20H19BrN2O2S (430.03505340000004)
9-Acetoxymethyl-4,6-diformyl-3,8-dihydroxy-1-methyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carbonsaeure|9-acetoxymethyl-4,6-diformyl-3,8-dihydroxy-1-methyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carboxylic acid
(2R,3S,4R,5S,6S,7R,E)-2,3,5,6,7,15-hexachloropentadec-14-en-4-ol
5-{4-[4-(5-pent-1,3-diynylthiophen-2-yl)-but-3-ynyloxy]-but-1-ynyl}-2,2-bithiophene|echinoetherthiophene
14-hydroxy-8beta-(3-chloro-2-hydroxyisobutyryloxy)-3-chlorodehydroleucodin|14-hydroxy-8beta-<3-chloro-2-hydroxyisobutyryloxy>-3-chlorodehydroleucodin
Bicalutamide
C18H14F4N2O4S (430.06103720000004)
L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BB - Anti-androgens D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C146993 - Androgen Receptor Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4405; ORIGINAL_PRECURSOR_SCAN_NO 4401 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4432; ORIGINAL_PRECURSOR_SCAN_NO 4429 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4382; ORIGINAL_PRECURSOR_SCAN_NO 4377 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4426; ORIGINAL_PRECURSOR_SCAN_NO 4422 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4399; ORIGINAL_PRECURSOR_SCAN_NO 4398 CONFIDENCE standard compound; INTERNAL_ID 519; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4400; ORIGINAL_PRECURSOR_SCAN_NO 4397 CONFIDENCE standard compound; INTERNAL_ID 2349 CONFIDENCE standard compound; INTERNAL_ID 8615 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2809
methyl 3,5-dichloro-2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate
C18H16Cl2O8 (430.02221959999997)
methyl 3,5-dichloro-2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate [IIN-based: Match]
C18H16Cl2O8 (430.02221959999997)
methyl 3,5-dichloro-2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate [IIN-based on: CCMSLIB00000847501]
C18H16Cl2O8 (430.02221959999997)
Cys Cys Cys Cys
SNS-314
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
2-Methyl-2-propanyl 4-hydroxy-8-iodo-5,7-dimethoxy-2-naphthoate
Methyl 4-acetoxy-8-iodo-5,7-dimethoxy-2-naphthoate
Diphenyl(4-fluorophenyl)sulphoniumtrifluoromethanesulphonate
4,8-diamino-9,10-dihydro-1,5-dihydroxy-9,10-dioxoanthracene-2,6-disulphonic acid
11-Morpholino-dibenzo[b,f][1,4]thiazepine
C16H13BrF2N2O3S (429.97982720000005)
bis(2,3-dichloropropyl) octyl phosphate
C14H27Cl4O4P (430.04009920000004)
Isopropylidene(cyclopentadienyl-9-fluorenyl) zirconium dichloride
C21H18Cl2Zr (429.98325679999994)
N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(2-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide
C18H14F4N2O4S (430.06103720000004)
1-BENZYL-4-(2-BROMO-BENZENESULFONYL)-PIPERAZINE HYDROCHLORIDE
C17H20BrClN2O2S (430.01173100000005)
2-Pyridinamine, 5-iodo-3-nitro-6-[2-(4-nitrophenyl)ethoxy]
SulfaMide, N-[5-(4-broMophenyl)-6-(2-hydroxyethoxy)-4-pyriMidinyl]-N-propyl-
bis(trifluoromethylsulfonyl)azanide,1-butyl-3-methylpyridin-1-ium
Dinsed
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
1-(3-Cyanopropyl)-3-methylimidazolium bis(trifluoromethylsulfonyl)amide
sodium 1-amino-9,10-dihydro-9,10-dioxo-4-o-toluidinoanthracene-2-sulphonate
C21H15N2NaO5S (430.05993400000006)
N-(5-(1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyramide
C17H14Cl2F2N4OS (430.02333980000003)
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
5-[(2,4-Dinitrophenyl)amino]-2-anilinobenzenesulphonic acid
N-[5-(1H-benzimidazol-2-ylmethylidene)-4-oxo-2-sulfanylidene-3-thiazolidinyl]-4-methylbenzenesulfonamide
6-Amino-2-carbazoyl-1,3-diketo-benzo[de]isoquinoline-5,8-disulfonic acid
2,3,3,3-tetrafluoro-2-(1,1,2,2,3,3,4,4,5,5,5-undecafluoropentoxy)propanoic Acid
N-(5-bromo-8-quinolinyl)-5-[(4-chloro-1-pyrazolyl)methyl]-2-furancarboxamide
2-(5-bromothiophen-2-yl)-N-(4-methylpiperazin-1-yl)quinoline-4-carboxamide
N-[5-[[2-(2-methyl-2,3-dihydroindol-1-yl)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide
3-[[[[[5-(4-Chlorophenyl)-2-furanyl]-oxomethyl]amino]-sulfanylidenemethyl]amino]-4-methoxybenzoic acid
C20H15ClN2O5S (430.03901700000006)
1-(3,4-Dichlorophenyl)-3-[diethoxyphosphoryl(phenyl)methyl]urea
C18H21Cl2N2O4P (430.06159360000004)
3-(4-Methylphenyl)sulfonylpropanoic acid [2-[(3,5-dichloro-2-pyridinyl)amino]-2-oxoethyl] ester
3-(Benzenesulfonyl)propanoic acid [2-[(3,5-dichloro-4-methyl-2-pyridinyl)amino]-2-oxoethyl] ester
5-[4-({4-[5-(penta-1,3-diyn-1-yl)thiophen-2-yl]but-3-yn-1-yl}oxy)but-1-yn-1-yl]-2,2'-bithiophene
(2s,3s,5s)-5-bromo-2-[(1r,3s,4s)-4-bromo-3-chloro-4-methylcyclohexyl]-2,6,6-trimethyloxan-3-ol
3-(acetyloxy)-2-(dibromomethyl)-2-hydroxy-6-propyloxan-4-yl acetate
5,13,15-trichloro-6,14-dihydroxy-4,12-dipropyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
C19H17Cl3O5 (430.01415220000007)
18,18-dibromooctadec-17-en-5,7-diynoic acid
C18H24Br2O2 (430.01429239999993)
(2s,3s,5s)-5-bromo-2-[(1r,3r,4r)-3-bromo-4-chloro-4-methylcyclohexyl]-2,6,6-trimethyloxan-3-ol
9-chloro-6,10-dihydroxy-20-methoxy-2,12,21-trioxahexacyclo[9.9.1.1¹,¹³.1³,⁷.0¹¹,²³.0¹⁷,²²]tricosa-3,5,7(23),13(22),14,16-hexaene-8,18-dione
(2r,3r,4s,6r)-3-(acetyloxy)-2-(dibromomethyl)-2-hydroxy-6-propyloxan-4-yl acetate
(1s,9s,10s,11s,20r)-9-chloro-6,10-dihydroxy-20-methoxy-2,12,21-trioxahexacyclo[9.9.1.1¹,¹³.1³,⁷.0¹¹,²³.0¹⁷,²²]tricosa-3,5,7(23),13(22),14,16-hexaene-8,18-dione
5-bromo-2-(3-bromo-4-chloro-4-methylcyclohexyl)-2,6,6-trimethyloxan-3-ol
3-bromo-1-(3-bromo-5-hydroxy-1,2,2-trimethylcyclopentyl)-4-chloro-4-methylcyclohexan-1-ol
(1r,3s,4s)-3-bromo-1-[(1s,3s,5r)-3-bromo-5-hydroxy-1,2,2-trimethylcyclopentyl]-4-chloro-4-methylcyclohexan-1-ol
8-chloro-6-(hydroxymethyl)-9-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 3-chloro-2-hydroxy-2-methylpropanoate
{4-formyl-5,13,17-trihydroxy-7-methyl-9,15-dioxo-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3,5,7,12,14(18)-hexaen-12-yl}methyl acetate
(2r,3s,4r,5s,6s,7r,14e)-2,3,5,6,7,15-hexachloropentadec-14-en-4-ol
6,13,15-trichloro-5,14-dihydroxy-7,12-dipropyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
C19H17Cl3O5 (430.01415220000007)
7,13,15-trichloro-6,14-dihydroxy-4,12-dipropyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
C19H17Cl3O5 (430.01415220000007)
7-[(acetyloxy)methyl]-4,15-diformyl-6,14-dihydroxy-12-methyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-5-carboxylic acid
2-[2,4-dichloro-5-hydroxy-6-(methoxycarbonyl)-3-methylphenoxy]-3,5-dimethoxybenzoic acid
C18H16Cl2O8 (430.02221959999997)
(3ar,4r,9ar,9br)-8-chloro-6-(hydroxymethyl)-9-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl (2r)-3-chloro-2-hydroxy-2-methylpropanoate
methyl 3,5-dichloro-2-hydroxy-6-[4-hydroxy-2-methoxy-6-(methoxycarbonyl)phenoxy]-4-methylbenzoate
C18H16Cl2O8 (430.02221959999997)